LUPIN.NS
Price:
$2098.8
Market Cap:
$958.65B
Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health, and anti-tuberculosis. The company is also involved in the provision of biosimilar and over-the-counter products; specialty products; and drug discovery and development programs in the therapeutic areas of oncology, immunology, and metabolic disorders, as well as b...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2001-09-10
Stock Exchange
NSE
Ticker
LUPIN.NS
According to Lupin Limited’s latest financial reports and current stock price. The company's current PE Ratio is 22.22. This represents a change of -4.89% compared to the average of 23.36 of the last 4 quarters.
The mean historical PE Ratio of Lupin Limited over the last ten years is 30.45. The current 22.22 PE Ratio has changed 7.20% with respect to the historical average. Over the past ten years (40 quarters), LUPIN.NS's PE Ratio was at its highest in in the June 2020 quarter at 97.00. The PE Ratio was at its lowest in in the June 2022 quarter at -77.93.
Average
30.45
Median
33.90
Minimum
-99.09
Maximum
140.27
Discovering the peaks and valleys of Lupin Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 448.00%
Maximum Annual PE Ratio = 140.27
Minimum Annual Increase = -410.41%
Minimum Annual PE Ratio = -99.09
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 27.28 | -29.67% |
| 2024 | 38.78 | -43.72% |
| 2023 | 68.91 | -410.41% |
| 2022 | -22.20 | -158.12% |
| 2021 | 38.19 | -138.54% |
| 2020 | -99.09 | -273.45% |
| 2019 | 57.13 | -59.27% |
| 2018 | 140.27 | 448.00% |
| 2017 | 25.60 | -13.55% |
| 2016 | 29.61 | -21.57% |
The current PE Ratio of Lupin Limited (LUPIN.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
44.99
5-year avg
30.19
10-year avg
30.45
Lupin Limited’s PE Ratio is greater than Zydus Lifesciences Limited (19.05), greater than Zydus Lifesciences Limited (19.05), greater than Dr. Reddy's Laboratories Limited (18.16), greater than Dr. Reddy's Laboratories Limited (18.16), less than Mankind Pharma Limited (51.99), less than Mankind Pharma Limited (51.99), greater than Aurobindo Pharma Limited (20.66), less than Alkem Laboratories Limited (28.74), less than Alkem Laboratories Limited (28.74), greater than Aurobindo Pharma Limited (20.66),
| Company | PE Ratio | Market cap |
|---|---|---|
| 19.05 | $937.26B | |
| 19.05 | $937.26B | |
| 18.16 | $1.06T | |
| 18.16 | $1.06T | |
| 51.99 | $910.44B | |
| 51.99 | $910.01B | |
| 20.66 | $707.18B | |
| 28.74 | $678.59B | |
| 28.74 | $680.24B | |
| 20.66 | $707.10B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lupin Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lupin Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Lupin Limited's PE Ratio?
How is the PE Ratio calculated for Lupin Limited (LUPIN.NS)?
What is the highest PE Ratio for Lupin Limited (LUPIN.NS)?
What is the 3-year average PE Ratio for Lupin Limited (LUPIN.NS)?
What is the 5-year average PE Ratio for Lupin Limited (LUPIN.NS)?
How does the current PE Ratio for Lupin Limited (LUPIN.NS) compare to its historical average?